In situ detection of alkaline phosphatase in a cisplatin-induced acute kidney injury model with a fluorescent/photoacoustic bimodal molecular probe

Kidneys play an important part in drug metabolism and excretion. High local concentration of drugs or drug allergies often cause acute kidney injury (AKI). Identification of effective biomarkers of initial stage AKI and constructing activable molecular probes with excellent detection properties for...

Full description

Bibliographic Details
Main Authors: Xingwang Chen, Zhiyang Yuwen, Yixing Zhao, Haixia Li, Kang Chen, Hongwen Liu
Format: Article
Language:English
Published: Frontiers Media S.A. 2022-11-01
Series:Frontiers in Bioengineering and Biotechnology
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fbioe.2022.1068533/full
_version_ 1811316827999961088
author Xingwang Chen
Zhiyang Yuwen
Yixing Zhao
Haixia Li
Kang Chen
Kang Chen
Hongwen Liu
Hongwen Liu
author_facet Xingwang Chen
Zhiyang Yuwen
Yixing Zhao
Haixia Li
Kang Chen
Kang Chen
Hongwen Liu
Hongwen Liu
author_sort Xingwang Chen
collection DOAJ
description Kidneys play an important part in drug metabolism and excretion. High local concentration of drugs or drug allergies often cause acute kidney injury (AKI). Identification of effective biomarkers of initial stage AKI and constructing activable molecular probes with excellent detection properties for early evaluation of AKI are necessary, yet remain significant challenges. Alkaline phosphatase (ALP), a key hydrolyzing protease, exists in the epithelial cells of the kidney and is discharged into the urine following kidney injury. However, no studies have revealed its level in drug-induced AKI. Existing ALP fluorescent molecular probes are not suitable for testing and imaging of ALP in the AKI model. Drug-induced AKI is accompanied by oxidative stress, and many studies have indicated that a large increase in reactive oxygen species (ROS) occur in the AKI model. Thus, the probe used for imaging of AKI must be chemically stable in the presence of ROS. However, most existing near-infrared fluorescent (NIRF) ALP probes are not stable in the presence of ROS in the AKI model. Hence, we built a chemically stable molecular sensor (CS-ALP) to map ALP level in cisplatin-induced AKI. This novel probe is not destroyed by ROS generated in the AKI model, thus allowing high-fidelity imaging. In the presence of ALP, the CS-ALP probe generates a new absorbance peak at 685 nm and a fluorescent emission peak at 716 nm that could be used to “turn on” photoacoustic (PA) and NIRF imaging of ALP in AKI. Levels of CS-ALP build up rapidly in the kidney, and CS-ALP has been successfully applied in NIRF/PA bimodal in vivo imaging. Through the NIRF/PA bimodal imaging results, we demonstrate that upregulated expression of ALP occurs in the early stages of AKI and continues with injury progression.
first_indexed 2024-04-13T11:56:09Z
format Article
id doaj.art-ac8ec97468ee43c083c57b32f080928e
institution Directory Open Access Journal
issn 2296-4185
language English
last_indexed 2024-04-13T11:56:09Z
publishDate 2022-11-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Bioengineering and Biotechnology
spelling doaj.art-ac8ec97468ee43c083c57b32f080928e2022-12-22T02:47:55ZengFrontiers Media S.A.Frontiers in Bioengineering and Biotechnology2296-41852022-11-011010.3389/fbioe.2022.10685331068533In situ detection of alkaline phosphatase in a cisplatin-induced acute kidney injury model with a fluorescent/photoacoustic bimodal molecular probeXingwang Chen0Zhiyang Yuwen1Yixing Zhao2Haixia Li3Kang Chen4Kang Chen5Hongwen Liu6Hongwen Liu7Department of Hepatobiliary Surgery, The First Affiliated Hospital of Hunan Normal University (Hunan Provincial People’s Hospital), Hunan Normal University, Changsha, ChinaDepartment of Hepatobiliary Surgery, The First Affiliated Hospital of Hunan Normal University (Hunan Provincial People’s Hospital), Hunan Normal University, Changsha, ChinaDepartment of Hepatobiliary Surgery, The First Affiliated Hospital of Hunan Normal University (Hunan Provincial People’s Hospital), Hunan Normal University, Changsha, ChinaDepartment of Hepatobiliary Surgery, The First Affiliated Hospital of Hunan Normal University (Hunan Provincial People’s Hospital), Hunan Normal University, Changsha, ChinaDepartment of Hepatobiliary Surgery, The First Affiliated Hospital of Hunan Normal University (Hunan Provincial People’s Hospital), Hunan Normal University, Changsha, ChinaKey Laboratory of Chemical Biology and Traditional Chinese Medicine Research, College of Chemistry and Chemical Engineering, Hunan Normal University, Changsha, ChinaDepartment of Hepatobiliary Surgery, The First Affiliated Hospital of Hunan Normal University (Hunan Provincial People’s Hospital), Hunan Normal University, Changsha, ChinaKey Laboratory of Chemical Biology and Traditional Chinese Medicine Research, College of Chemistry and Chemical Engineering, Hunan Normal University, Changsha, ChinaKidneys play an important part in drug metabolism and excretion. High local concentration of drugs or drug allergies often cause acute kidney injury (AKI). Identification of effective biomarkers of initial stage AKI and constructing activable molecular probes with excellent detection properties for early evaluation of AKI are necessary, yet remain significant challenges. Alkaline phosphatase (ALP), a key hydrolyzing protease, exists in the epithelial cells of the kidney and is discharged into the urine following kidney injury. However, no studies have revealed its level in drug-induced AKI. Existing ALP fluorescent molecular probes are not suitable for testing and imaging of ALP in the AKI model. Drug-induced AKI is accompanied by oxidative stress, and many studies have indicated that a large increase in reactive oxygen species (ROS) occur in the AKI model. Thus, the probe used for imaging of AKI must be chemically stable in the presence of ROS. However, most existing near-infrared fluorescent (NIRF) ALP probes are not stable in the presence of ROS in the AKI model. Hence, we built a chemically stable molecular sensor (CS-ALP) to map ALP level in cisplatin-induced AKI. This novel probe is not destroyed by ROS generated in the AKI model, thus allowing high-fidelity imaging. In the presence of ALP, the CS-ALP probe generates a new absorbance peak at 685 nm and a fluorescent emission peak at 716 nm that could be used to “turn on” photoacoustic (PA) and NIRF imaging of ALP in AKI. Levels of CS-ALP build up rapidly in the kidney, and CS-ALP has been successfully applied in NIRF/PA bimodal in vivo imaging. Through the NIRF/PA bimodal imaging results, we demonstrate that upregulated expression of ALP occurs in the early stages of AKI and continues with injury progression.https://www.frontiersin.org/articles/10.3389/fbioe.2022.1068533/fulloxidative stressacute kidney injuryalkaline phosphatasefluorescent probephotoacoustic (optoacoustic) imaging
spellingShingle Xingwang Chen
Zhiyang Yuwen
Yixing Zhao
Haixia Li
Kang Chen
Kang Chen
Hongwen Liu
Hongwen Liu
In situ detection of alkaline phosphatase in a cisplatin-induced acute kidney injury model with a fluorescent/photoacoustic bimodal molecular probe
Frontiers in Bioengineering and Biotechnology
oxidative stress
acute kidney injury
alkaline phosphatase
fluorescent probe
photoacoustic (optoacoustic) imaging
title In situ detection of alkaline phosphatase in a cisplatin-induced acute kidney injury model with a fluorescent/photoacoustic bimodal molecular probe
title_full In situ detection of alkaline phosphatase in a cisplatin-induced acute kidney injury model with a fluorescent/photoacoustic bimodal molecular probe
title_fullStr In situ detection of alkaline phosphatase in a cisplatin-induced acute kidney injury model with a fluorescent/photoacoustic bimodal molecular probe
title_full_unstemmed In situ detection of alkaline phosphatase in a cisplatin-induced acute kidney injury model with a fluorescent/photoacoustic bimodal molecular probe
title_short In situ detection of alkaline phosphatase in a cisplatin-induced acute kidney injury model with a fluorescent/photoacoustic bimodal molecular probe
title_sort in situ detection of alkaline phosphatase in a cisplatin induced acute kidney injury model with a fluorescent photoacoustic bimodal molecular probe
topic oxidative stress
acute kidney injury
alkaline phosphatase
fluorescent probe
photoacoustic (optoacoustic) imaging
url https://www.frontiersin.org/articles/10.3389/fbioe.2022.1068533/full
work_keys_str_mv AT xingwangchen insitudetectionofalkalinephosphataseinacisplatininducedacutekidneyinjurymodelwithafluorescentphotoacousticbimodalmolecularprobe
AT zhiyangyuwen insitudetectionofalkalinephosphataseinacisplatininducedacutekidneyinjurymodelwithafluorescentphotoacousticbimodalmolecularprobe
AT yixingzhao insitudetectionofalkalinephosphataseinacisplatininducedacutekidneyinjurymodelwithafluorescentphotoacousticbimodalmolecularprobe
AT haixiali insitudetectionofalkalinephosphataseinacisplatininducedacutekidneyinjurymodelwithafluorescentphotoacousticbimodalmolecularprobe
AT kangchen insitudetectionofalkalinephosphataseinacisplatininducedacutekidneyinjurymodelwithafluorescentphotoacousticbimodalmolecularprobe
AT kangchen insitudetectionofalkalinephosphataseinacisplatininducedacutekidneyinjurymodelwithafluorescentphotoacousticbimodalmolecularprobe
AT hongwenliu insitudetectionofalkalinephosphataseinacisplatininducedacutekidneyinjurymodelwithafluorescentphotoacousticbimodalmolecularprobe
AT hongwenliu insitudetectionofalkalinephosphataseinacisplatininducedacutekidneyinjurymodelwithafluorescentphotoacousticbimodalmolecularprobe